Boehringer Ingelheim subsidiary NBE Therapeutics has opened its new antibody-drug conjugates (ADC) R&D facility in Basel, ...

Late-stage pipeline products anticipated to reach the uveitis market during the forecast period will introduce new mechanisms ...

The EC has approved Daiichi Sankyo and AstraZeneca’s Enhertu for use as a single agent to treat adults with certain breast ...

This week, the Trump administration followed through on its planned mass layoffs at agencies under the US Department of ...

Sanofi's reversible BTK inhibitor rilzabrutinib has gained the US Food and Drug Administration’s (FDA) orphan drug ...

If preclinical findings were translated into the clinic, they could shorten the CAR-T generation lead time from two weeks to ...

According to a factsheet published by the Trump administration, pharmaceuticals are exempted from the tariffs – for now.

Roche outlined how digital health technologies (DHTs) provide more sensitive measures of disease progression in early ...

Atsena Therapeutics has completed an oversubscribed Series C financing round, raising $150m to support the advancement of ...

The FDA has granted accelerated approval to Novartis’ Vanrafia for adults with primary immunoglobulin A nephropathy (IgAN).

Astellas Pharma has entered a strategic partnership with the JFCR to expedite research in translational and clinical oncology ...

Neurona will kick start a Phase III trial in H2 2025 investigating NRTX-1001 in patients with a type of drug-resistant ...